Product listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?


Product listing agreements (PLAs) with pharmaceutical manufacturers are increasingly viewed as an innovative and useful tool in the effort to control drug expenditures. To date, Quebec is the only province that has been reluctant to enter into such agreements, arguing that their confidential nature may lead to a disparity in coverage between individuals… (More)


2 Figures and Tables

Slides referencing similar topics